Back to Search

CELESTIA HIGANO, MD

MD

Hematology & Oncology Physician

NPI: 1972689727Individual

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

00019850(WA)

Research & Publications (20)

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.
PMID 19536890·Cancer·2009
3-trial
Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer.
PMID 18646045·Cancer·2008
3-trial
Androgen-deprivation-therapy-induced fractures in men with nonmetastatic prostate cancer: what do we really know?
PMID 18185511·Nat Clin Pract Urol·2008
6-review
Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.
PMID 18404692·Cancer·2008
8-other
Safety analysis of repeated high doses of samarium-153 lexidronam in men with hormone-naive prostate cancer metastatic to bone.
PMID 18501082·Clin Genitourin Cancer·2008
8-other
Androgen deprivation therapy: monitoring and managing the complications.
PMID 16861122·Hematol Oncol Clin North Am·2006
6-review
Current status of treatment for patients with metastatic prostate cancer.
PMID 16018832·Can J Urol·2005
6-review
Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
PMID 15123412·Urol Clin North Am·2004
4-observational
Bone mineral density in patients with prostate cancer without bone metastases treated with intermittent androgen suppression.
PMID 15596194·Urology·2004
8-other
Safety and biological activity of repeated doses of recombinant human Flt3 ligand in patients with bone scan-negative hormone-refractory prostate cancer.
PMID 14977818·Clin Cancer Res·2004
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3515 E SPRING ST
SEATTLE, WA 98122

Quick Facts

NPI
1972689727
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile